Recursion Pharmaceuticals
clinical target alpha and gamma reaching enabling studies in continuing to augment our digital chemistry and predictive capabilities property assessment continuing to drive potential first in disease or first in class programs at greater and scale looking ahead beyond | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
72 of 143
Related slides by other companies
DocGo
Investor Day
June 2023
covered lives with potential access to programs | DocGo
AbCellera
Results
August 2022
i a a mae mise to unlock early stage innovators potential programs new programs under contract targets targets versant | AbCellera
AbCellera
Investor Conference
April 2023
partnered programs technology development efforts with potential to generate first in class wholly owned assets ama | AbCellera
AbCellera
Investor Conference
January 2023
partnered programs technology development efforts with potential to generate first in class wholly owned assets ama | AbCellera
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io